Conversion therapy from unresectable stage IIIC non-small-cell lung cancer to radical surgery via anti-PD-1 immunotherapy combined with chemotherapy and anti-angiogenesis: A case report and literature review

The prognosis of patients with stage IIIC non-small-cell lung cancer (NSCLC) is poor due to the loss of surgical treatment opportunities. Improving the prognosis of these patients with IIIC NSCLC urgently needs to be addressed. Here, we report a stage IIIC (T4N3M0 IIIC (AJCC 8th)) NSCLC patient trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Guohua, Zhou, Shuimei, Xu, Tangpeng, Huang, Yabing, Li, Xiangpan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515488/
https://www.ncbi.nlm.nih.gov/pubmed/36185263
http://dx.doi.org/10.3389/fonc.2022.954685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515488/
https://www.ncbi.nlm.nih.gov/pubmed/36185263
http://dx.doi.org/10.3389/fonc.2022.954685

Ejemplares similares